A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
about
Contaminated heparin associated with adverse clinical events and activation of the contact systemWilliams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathwaysProcessing of Factor XII during Inflammatory ReactionsAnaphylactic release of a prekallikrein activator from human lung in vitro.Control of human coagulation by recombinant serine proteases. Blood clotting is activated by recombinant factor XII deleted of five regulatory domains.Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.Inhibitors of kallikrein in human plasma.Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents.Partial purification and characterization of contact activation cofactor.Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.Kinins and rhinitis.Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation.Acute inflammation. A review.Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency.The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).Modulation of function of the activated first component of complement by a fragment derived from serum. I. Effect on early components of complementA prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.Plasma prekallikrein: isolation, characterization, and mechanism of activation.The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.Activation of Hageman factor in solid and fluid phases. A critical role of kallikreinSecretion of plasminogen activator by stimulated macrophages.Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin.Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.Streptococcal cell walls and synovial cell activation. Stimulation of synovial fibroblast plasminogen activator activity by monocytes treated with group A streptococcal cell wall sonicates and muramyl dipeptide.Purification and partial characterization of the nephritis strain-associated protein from Streptococcus pyogenes, group A.Formation and structure of human Hageman factor fragments.Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.Purification of high molecular weight kininogen and the role of this agent in blood coagulation.Association of factor XI and high molecular weight kininogen in human plasma.Plasma kallikrein activation and inhibition during typhoid fever.Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.
P2860
Q24619723-B0C1CEC4-0178-4ADD-985F-00DECA98E3E8Q24634211-052AF553-2AF3-4D61-8997-111F1B77CF36Q28077182-E1EA3823-662F-40A1-9A20-0F26D04A4620Q28365898-36B38B0E-E269-4BB7-88FF-409C49CC2FCAQ30984071-FE7703CB-CD71-4BB1-A416-D2C9C27FFAC9Q33366163-29C308AD-67BE-419E-8E4A-DA05EA7B14D8Q33854333-E5465CD5-01A4-44F4-87F7-814E75CF4157Q34071315-AC8C156A-178C-4D66-A83C-F35538E8A9DBQ34462395-B173D264-8BEA-4F55-8BD5-9F745CE617C6Q34470330-B10F13E4-BE38-418C-97A2-0D3147CBF5F1Q34483720-55DAB7A0-FEB6-4DE0-B484-50D1CECE7661Q34505602-C8947D57-685F-4FEE-8FEC-8B40B8CA5106Q34579883-354078BF-A0A0-4C30-8A1F-9F210F1D43D5Q35207230-6940B483-0997-445F-BC65-D5E6D9C95A67Q35208694-C2A66D5B-F927-4CF8-B503-7EC72CAD5B1AQ35838046-261F4FE3-BEB2-4BCB-9F71-D296BD1A8C77Q35880507-90C37ED3-AE9B-41B1-B108-A9A8E2A59D4FQ36076876-869725DB-BC28-4645-9251-7D75F69C89BFQ36144212-39A3FE4D-35CC-4865-B393-A07B8445B0E9Q36270989-DC6B7B7B-69BA-45EE-B834-102E77C6EBB6Q36271325-0DDA0AC0-A952-47D2-A63A-592E7DB4F10BQ36271381-3C27F887-3331-4540-AD3A-1597E175809EQ36271407-A8188351-2694-4E21-8206-C8FC8FD8BDF7Q36272174-BDE65E47-3B76-4E9E-9EFB-F37D51CBECB8Q36272208-400E9120-70BE-42B2-8352-0A05EFF4F2CFQ36272715-31EADAFA-03E1-41B3-B604-BC99CFF07E81Q36273101-05EE7774-9906-477E-8A0F-57AAE06E57E8Q36273769-7F60ABCB-A5E9-4B06-B1FA-9D258F852AF0Q36340709-6B2D8CEA-D60B-4C10-B2DC-52EC83C48518Q36346618-6195CBF7-AE8E-4BE8-9B8B-8E7592846AA2Q36351641-0E70DE29-34F9-485D-AA39-3A4A69A6D718Q36986168-6FCAE86C-D0BA-4F8E-8038-D85E03A15A19Q37019645-B9605031-48A7-466F-AE8D-F67372D87C36Q37045271-E422E0B2-7931-4F8B-B43F-CF845191289FQ37045297-705A40F1-817D-4123-B751-6D8806D9FD13Q37046547-DA417413-29F6-4645-9613-BC7F8F4DFBE5Q37049066-2D70CB56-FCF2-469E-8FE1-DC6B35052DD5Q37050492-14C76F67-81CA-4313-8B55-1C240DDB0DE8Q37316920-6554F089-6D07-4D6E-A701-C4E375E0DB6CQ37402410-C524AFBD-5EB4-4D41-8926-E563FED48F83
P2860
A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh
1971年學術文章
@zh-hant
name
A prealbumin activator of prek ...... tor by digestion with plasmin.
@ast
A prealbumin activator of prek ...... tor by digestion with plasmin.
@en
type
label
A prealbumin activator of prek ...... tor by digestion with plasmin.
@ast
A prealbumin activator of prek ...... tor by digestion with plasmin.
@en
prefLabel
A prealbumin activator of prek ...... tor by digestion with plasmin.
@ast
A prealbumin activator of prek ...... tor by digestion with plasmin.
@en
P2860
P356
P1476
A prealbumin activator of prek ...... tor by digestion with plasmin.
@en
P2093
P2860
P304
P356
10.1084/JEM.133.4.696
P407
P577
1971-04-01T00:00:00Z